Characterization of the absorption of theophylline from immediate- and controlled-release dosage forms with a numerical approach using the in vitro dissolution-permeation process using Caco-2 cells

被引:13
作者
Noureddine, N
Zerrouk, N [1 ]
Nicolis, I
Allain, P
Sfar, S
Chaumeil, JC
机构
[1] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharm Galen Lab, Paris, France
[2] Fac Pharm Monastir, Pharm Galen Lab, Monastir, Tunisia
[3] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Biomath, Paris, France
关键词
theophylline; dissolution; absorption; Caco-2; predicting system;
D O I
10.1080/03639040500214589
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
After oral administration, drug absorption rate is recognized to be dependent on two major factors: dissolution and intestinal cells permeability. Caco-2 monolayer cells have been largely used as a permeation study model. In this study, a numerical approach funded on an exponential first-order time relationship was tested to compare immediate- and controlled-release tablets of theophylline using a dissolution- permeation system. The dissolution performance using USP II paddle apparatus was coupled to the permeability studies investigated in Caco-2 cell monolayers. The dissolved samples were taken at different times; their pH and osmolarity were adjusted to render them suitable to Caco-2 permeability studies ( osmolarity = 300 mosm, pH = 7.4). The experimental data show that the dissolution fits the exponential first-order relationship rate. The permeability values were in a range of 4.45 10(-6) - 5.28 10(-6) cm/s, and percentages of absorbed drug dose were dependent on the fraction initially present in the donor compartment, indicating that absorption of theophylline was dissolution rate limited. Plotting experimental absorbed fractions (F-a) against experimental dissolved fractions (F-d) show that permeation is the rate-limiting step in drug absorption process in the extended release form of theophylline. Our results demonstrate a general agreement between observed F-a/F-d relationships and theoretical F-a/ F-d relationships obtained with our approach funded on dissolution and permeation behavior. We concluded that the couple dissolution- caco-2 system could be a useful tool to characterize intestinal permeation for a new formulation of a drug compared with the conventional one.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 20 条
[1]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]
CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[3]
BOHETS H, 2001, CURR TOP MED CHEM, V5, P367
[4]
Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight [J].
Camenisch, G ;
Alsenz, J ;
van de Waterbeemd, H ;
Folkers, G .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (04) :313-319
[5]
In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs [J].
Dressman, JB ;
Reppas, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 :S73-S80
[6]
Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[7]
Dunne A, 1999, STAT MED, V18, P1865, DOI 10.1002/(SICI)1097-0258(19990730)18:14<1865::AID-SIM223>3.0.CO
[8]
2-P
[9]
Biopharmaceutical characterization of oral immediate release drug products.: In vitro in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin [J].
Frick, A ;
Möller, H ;
Wirbitzki, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 46 (03) :305-311
[10]
Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system [J].
Ginski, MJ ;
Polli, JE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 177 (01) :117-125